Medical Device Deals Update, March 2016
Executive Summary
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2016.
You may also be interested in...
Merit Faces Subpoena Over Marketing
The US Department of Justice is behind the Oct. 19 subpoena, which asks for more information and documents related to Merit’s marketing and promotional practices.
FDA Greenlights Historical Control In Trial Of Regentis' GelrinC Knee Repair Material
The pivotal clinical study will support a US pre-market approval to allow Regentis Biomaterials to market GelrinC for the repair of focal knee cartilage defects in the knee, the largest unmet need in orthopedic sports medicine, according to the company.
Inter Parfums Has ‘Best Year’ In 2021 As Sales Grow 23% Compared With Pre-Pandemic
New York-based fragrance manufacturer and distributor Inter Parfums reports full-year 2021 sales growth of 23% to $879.6m, significantly higher than the $810m projected in October, with successful launches and integration of new fragrance licenses. The NPD Group stated in a 24 January report that fragrance was the best-performing prestige beauty category in the US in 2021, with sales up 49%.